{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:33:07Z","timestamp":1778293987419,"version":"3.51.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>A 17-year-old girl developed invasive rhinocerebral mucormycosis during intensive re-induction chemotherapy for relapsed pre-B acute lymphoblastic leukemia. Due to the high case fatality rate for invasive mucormycosis in profoundly immunosuppressed patients, an aggressive treatment regimen was pursued. In addition to the standard of care treatments with intravenous amphotericin and aggressive surgical debridements, she received intraventricular amphotericin to the brain via an Ommaya reservoir, hyperbaric oxygen treatments, filgrastim, intravenous immunoglobulin and antifungal in vitro synergy testing to allow for more targeted antifungal therapy with the addition of micafungin. After a 3-month treatment course, it was determined that her mucormycosis was under appropriate control, allowing her to continue treatment for her leukemia with hematopoietic stem cell transplant with a plan for continued intravenous antifungal therapy through engraftment.<\/jats:p>","DOI":"10.1097\/inf.0000000000001839","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T20:46:46Z","timestamp":1510951606000},"page":"555-558","source":"Crossref","is-referenced-by-count":9,"title":["Multimodal Treatment of Rhinocerebral Mucormycosis in a Pediatric Patient With Relapsed Pre-B Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"37","author":[{"given":"Zephyr D.","family":"Dworsky","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California, San Diego"},{"name":"Rady Children\u2019s Hospital - San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Hospital - San Diego, California"},{"name":"Division of Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Brigger","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Hospital - San Diego, California"},{"name":"Division of Pediatric Otolaryngology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice L.","family":"Pong","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Hospital - San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis John","family":"Kuo","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Hospital - San Diego, California"},{"name":"Division of Pediatric Hematology-Oncology, University of California, San Diego, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2152-7806.182964","article-title":"An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis.","volume":"7","author":"Palejwala","year":"2016","journal-title":"Surg Neurol Int"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-012-0272-6","article-title":"Rhino-orbital-cerebral mucormycosis.","volume":"14","author":"Gamaletsou","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10006-011-0292-7","article-title":"Rhinocerebral mucormycosis\u2013a case report.","volume":"16","author":"Thomas","year":"2012","journal-title":"Oral Maxillofac Surg"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1871530316666161223145055","article-title":"Rhinocerebral mucormycosis with orosinusal involvement: diagnostic and surgical treatment guidelines.","volume":"16","author":"Giudice","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"suppl 1","key":"R5-20230912","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis.","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1469-0691.2010.03231.x","article-title":"Skull-base osteomyelitis: fungal vs. bacterial infection.","volume":"17","author":"Blyth","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2310\/7070.2005.04023","article-title":"Early identification of rhinocerebral mucormycosis.","volume":"34","author":"Safar","year":"2005","journal-title":"J Otolaryngol"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"suppl 3","key":"R9-20230912","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3340\/jkns.2010.47.1.74","article-title":"Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole.","volume":"47","author":"Yoon","year":"2010","journal-title":"J Korean Neurosurg Soc"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/08880018.2013.770587","article-title":"Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.","volume":"30","author":"Almannai","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0002-9394(14)73986-8","article-title":"Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis.","volume":"114","author":"De La Paz","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00006534-199809010-00030","article-title":"Hyperbaric oxygen therapy for cutaneous\/soft-tissue zygomycosis complicating diabetes mellitus.","volume":"102","author":"Bentur","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002341-199901000-00007","article-title":"Role of local amphotericin B therapy for sino-orbital fungal infections.","volume":"15","author":"Seiff","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00520-005-0910-8","article-title":"Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies.","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"R17-20230912","first-page":"203","article-title":"Invasive fungal sinusitis in patients undergoing bone marrow transplantation.","volume":"12","author":"Drakos","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.14597","article-title":"Granulocyte transfusions in the management of invasive fungal infections.","volume":"177","author":"West","year":"2017","journal-title":"Br J Haematol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1445-5994.1990.tb00377.x","article-title":"Mucor cerebral abscess associated with intravenous drug abuse.","volume":"20","author":"Fong","year":"1990","journal-title":"Aust N Z J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201806000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:47:49Z","timestamp":1694558869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201806000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001839","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}